Latest articles on Antiretrovirals

Six injections a year could stop new HIV infections

New research from seven countries in Africa signals the future of HIV prevention — but what can it learn from its past?

Eusebius McKaiser: A witness to Covid-19 stigma

Let us please not repeat the devastating Aids story where people died of shame rather than admit being infected by the virus

My late uncle, and the ethics of clinical trials in Africa

Despite the long history of medical racism, any potential Covid-19 vaccines must be tested in Africa — but not only on the continent

The quest for the (vaginal) ring

The HIV prevention tablet is now available in South Africa but popping a pill every day to stay HIV-negative may not be for everyone

On the road: Go inside the farm clinics making sure workers are never far from care

They're not only good for workers' health, they're good for business too.

Research: More than 50 000 teachers at public schools are living with HIV

The purpose of the research was to look at the health and wellbeing of public schools, with specific focus on the HIV profile of school leadership

Will South Africa reach its 90-90-90 HIV targets?

The country has made progress with its plans to prevent, treat and monitor HIV but still has a long way to go.

Six ways ARVs can help to end Aids by 2030

Science knows more than ever about how to use HIV treatment to prevent new infections but will it be enough to end Aids?

Health financing crisis threatens developing countries, experts say

Researchers predict that in 2040, low-income countries will spend just $0.03 on healthcare for every dollar that high-income countries spend.

Why Africa needs PrEP: A two-in-one pill to prevent HIV infection

Truvada, which contains two antiretrovirals, reduces the risk of HIV infection with up to 96%.

Survey uncovers shortages in critical medication

A survey of stock levels of HIV drugs is in stark contrast to health department claims that "there is no shortage".

Funding crunch threatens TAC

Aids is not over, says Archbishop Emeritus Desmond Tutu, but donors are pulling out of South Africa because it is a middle-income country.

Health-fad herb may reduce ARV efficacy, report warns

Experts believe Ginkgo biloba, a natural product used in vitamin supplements, may be harmful if taken together with HIV medication.

How true are reports of breakthrough Aids ‘cures’?

As the world recently marked World Aids Day, Africa Check has investigated the evidence behind three claims of an Aids breakthrough "cure".

Sanac hopes for three-million on ARVs by 2015

The South African National Aids Council says it aims to have three million people receiving antiretroviral therapy by 2015.

vital information

The Mail & Guardian’s essential coverage of the ongoing coronavirus crisis is free to read for everyone.

If you would like to support us, please consider taking out a subscription.

Latest

Judicial committee orders Mogoeng to apologise for SA-Israel remarks

The JCC said that by the chief justice straying into politics, he breached the judicial conduct code and ordered him to issue an apology and retraction

‘Doctors’ wives’ jump Covid queue

Private doctors and civilians have been exploiting gaps in the public health system to get vaccinated

Ithala fails to act against board chairperson over PPE scandal

Morar asked to settle with the state and pay back the profit he made on an irregular tender

Press Releases